Metabolic well being monitoring platform Vively has raised $1.6 million in a Seed spherical because it rolls out its Steady Glucose Monitoring (CGM) program to deal with pre-diabetes.
The spherical was led by Archangel Ventures with assist from Bupa Ventures, the VC arm of not-for-profit personal well being insurer Bupa, and others.
Archangel beforehand led 2022’s $1.5 million pre-Seed spherical, three months after cofounder and CEO Tim Veron launched the platform with Michael Pang.
Vively combines real-time glucose monitoring with AI-driven insights and training to assist customers perceive how their weight loss plan, sleep, stress, and exercise affect their well being and learn how to make small, measurable behavior adjustments.
The money injection coincides with the launch of the insurer-backed CGM program, which makes preventative well being extra accessible and sensible, in partnership with Bupa. Whereas CGM has been historically used for diabetes administration, is now being provided to assist early life-style intervention by way of a low-cost program.
“We’re constructing a future the place folks don’t wait to get sick earlier than taking management of their well being,” Veron stated.
“This partnership with Bupa and the backing of our traders accelerates our mission to shift healthcare from reactive to preventative, giving folks the instruments to behave on their metabolic well being earlier than it’s too late.”
He’s hoping the capital will assist the corporate develop from $3 million to $10m in annualised income over the subsequent 12-18 months.
Bupa APAC’s chief buyer and transformation officer, Danielle Handley, stated this funding and pilot is a strategic funding in preventative healthcare to enhance well being outcomes for his or her clients.
“By this funding and collaborative pilot, we see large potential in our partnership with Vively which shares our purpose of enabling preventative healthcare that’s extra related and buyer centric,” she stated.
Bupa members within the pilot obtain a CGM machine and app that screens their glucose ranges constantly. The information is analysed to supply tailor-made well being insights and life-style suggestions, supported by Vively’s group of dieticians and well being coaches.
Vively Well being CEO, Tim Veron, stated partnering with Bupa permits them to develop their footprint and shift healthcare from reactive to proactive.
“We imagine that everybody deserves entry to instruments that may assist enhance their well being outcomes, and this pilot is a serious step in direction of reaching that purpose. We’re actually enthusiastic about what we will obtain collectively as a part of this program and past,” Tim stated.
Interventions on the pre-diabetic stage might help forestall the onset of sort 2 diabetes, whereas a sustained enchancment in metabolic well being additionally decreases the danger of different continual circumstances together with weight problems and coronary heart illness.
